Summary of Key Points Core Viewpoint - 基石药业-B (02616.HK) announced the granting of stock options and restricted share units to employees and directors as part of its employee stock ownership plan and restricted share award plan following its initial public offering [1] Group 1: Stock Options - The board resolved to grant a total of 15,715,500 stock options to 96 option grantees on January 23, 2026 [1] - Among the total stock options granted, 7,000,000 options were awarded to one director, while 8,715,500 options were allocated to company employees, including senior management members [1] Group 2: Restricted Share Units - The board also resolved to grant a total of 8,055,000 restricted share units to 88 grantees on January 23, 2026 [1] - This total includes 4,270,000 restricted share units awarded to one director and 3,785,000 units granted to company employees, including senior management members [1]
基石药业-B(02616.HK)授出1571.6万份购股权及805.5万份受限制股份单位